Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Niacinamide 100mg tablets
0906022K0BCABAB
|
Niacinamide | Nicotinamide | Nutrition and Blood | No data available |
|
Niaspan 1g modified-release tablets
0212000U0BFACAX
|
Niaspan | Nicotinic acid | Cardiovascular System | No data available |
|
Niaspan 500mg modified-release tablets
0212000U0BFAAAV
|
Niaspan | Nicotinic acid | Cardiovascular System | No data available |
|
Niaspan 750mg modified-release tablets
0212000U0BFABAW
|
Niaspan | Nicotinic acid | Cardiovascular System | No data available |
|
Niaspan titration pack
0212000U0BFADAY
|
Niaspan | Nicotinic acid | Cardiovascular System | No data available |
|
Niatin 100mg tablets
0906022K0BDAEAB
|
Niatin | Nicotinamide | Nutrition and Blood | No data available |
|
Niatin 500mg capsules
0906022K0BDAAAG
|
Niatin | Nicotinamide | Nutrition and Blood | No data available |
|
Niatin 500mg tablets
0906022K0BDABAC
|
Niatin | Nicotinamide | Nutrition and Blood | No data available |
|
Niatin 50mg tablets
0906022K0BDACAA
|
Niatin | Nicotinamide | Nutrition and Blood | No data available |
|
Nibix 100mg capsules
0801050AABCAAAA
|
Nibix | Imatinib mesilate | Malignant Disease and Immunosuppression | No data available |
|
Nibix 400mg capsules
0801050AABCABAD
|
Nibix | Imatinib mesilate | Malignant Disease and Immunosuppression | No data available |
|
Nicardipine 20mg/5ml oral liquid
0206020Q0AAAFAF
|
Nicardipine hydrochloride | Nicardipine hydrochloride | Cardiovascular System | No data available |
|
Nicardipine 45mg modified-release capsules
0206020Q0AAADAD
|
Nicardipine hydrochloride | Nicardipine hydrochloride | Cardiovascular System | No data available |
|
Nice 'n Clear head lice lotion
091200000BEGCA0
|
Proprietary compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Nicef 250mg capsules
0501021M0BCAAAA
|
Nicef | Cefradine | Infections | No data available |
|
Nicef 500mg capsules
0501021M0BCABAB
|
Nicef | Cefradine | Infections | No data available |
|
Nicetile 500mg tablets
0206040ALBBABAB
|
Nicetile | Acetyl-l-carnitine | Cardiovascular System | No data available |
|
NicoBloc liquid
190500000BBDHA0
|
Proprietary compound preparation BNF 1905000 | Other preparations | Other Drugs and Preparations | No data available |
|
Nicobrevin capsules
0410020B0BKAAA0
|
Proprietary compound preparation BNF 0410020 | Nicotine | Central Nervous System | No data available |
|
Nicopass 1.5mg Fresh Mint lozenges
0410020B0BJAABP
|
Nicopass | Nicotine | Central Nervous System | No data available |
|
Nicopass 1.5mg Liquorice Mint lozenges
0410020B0BJABBP
|
Nicopass | Nicotine | Central Nervous System | No data available |
|
Nicopatch 14mg/24hours transdermal patches
0410020B0BIABAQ
|
Nicopatch | Nicotine | Central Nervous System | No data available |
|
Nicopatch 21mg/24hours transdermal patches
0410020B0BIACAR
|
Nicopatch | Nicotine | Central Nervous System | No data available |
|
Nicopatch 7mg/24hours transdermal patches
0410020B0BIAAAP
|
Nicopatch | Nicotine | Central Nervous System | No data available |
|
Nicorandil 10mg oral powder sachets
0206030N0AAAEAE
|
Nicorandil | Nicorandil | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.